SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-18-002475
Filing Date
2018-06-04
Accepted
2018-06-04 14:03:56
Documents
7
Period of Report
2018-05-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 8677
2 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 36199
3 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 6171
4 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 7757
5 GRAPHIC exhibit10-1x7x1.jpg GRAPHIC 23598
6 GRAPHIC tw.jpg GRAPHIC 1113
7 GRAPHIC fb.jpg GRAPHIC 1070
  Complete submission text file 0001062993-18-002475.txt   96063
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 18877618
SIC: 1000 Metal Mining